PO-0677: Vero SBRT for early stage lung cancer: a phase II trial with dynamic tracking in selected lesions. (May 2017) - Collen, C.; Van den Begin, R.; Boussaer, M.; Engels, B.; Dhont, J.; Burghelea, M.; Storme, G.; De Ridder, M.